| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −5.7× | −1.7× | |
| Price / Book | −14.3× | 2.0× | |
| Price / Sales | 2,825.7× | 3.9× | |
| Price / Free cash flow | −8.9× | −1.5× | |
| EV / EBITDA | −8.6× | −1.2× | |
| Earnings yield | −17.4% | −14.3% | |
| Free cash flow yield | −11.2% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,301.19 | +4.91% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.38 | +2.20% | $625.08B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $287.95 | +1.86% | $508.84B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $416.59 | +2.39% | $373.93B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.26 | +3.22% | $365.78B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.67 | +1.64% | $281.44B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $167.86 | +2.38% | $260.34B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.18 | +0.71% | $252.97B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.64 | +2.52% | $235.52B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.29 | +1.45% | $192.55B | 22.3× | 37.5% | +29.9% |
